Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 2/20 | 0.61 |
| ▸ | CASP6 | P55212 | 5/20 | 0.58 |
| ▸ | NSD2 | O96028 | 3/20 | 0.58 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.58 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.58 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.58 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.51 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.51 |
| ▸ | NT5E | P21589 | 3/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | SNCA | P37840 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1374756 | 0.90 | PRMT1 (0.70) | PRMT1CASP6NSD2DUSP3PTPN5 | |
| SCHEMBL37480409 | 0.90 | PRMT1 (0.70) | PRMT1CASP6NSD2DUSP3PTPN5 | |
| SCHEMBL9776574 | 0.89 | PRMT1 (0.68) | PRMT1CASP6NSD2DUSP3PTPN5 | |
| SCHEMBL29462031 | 0.84 | CASP6 (0.77) | PRMT1CASP6NSD2DUSP3PTPN5 | |
| SCHEMBL465086 | 0.84 | CASP6 (0.77) | PRMT1CASP6NSD2DUSP3PTPN5 | |
| SCHEMBL18268229 | 0.83 | PRMT1 (0.57) | PRMT1CASP6NSD2DUSP3PTPN5 | |
| Ammonia Solution, Strong SCHEMBL11667165 | 0.83 | CASP6 (0.74) | PRMT1CASP6NSD2DUSP3PTPN5 | |
| Potassium SCHEMBL18274860 | 0.83 | CASP6 (0.74) | PRMT1CASP6NSD2DUSP3PTPN5 | |
| SCHEMBL565058 | 0.83 | CASP6 (0.74) | PRMT1CASP6NSD2DUSP3PTPN5 | |
| SCHEMBL18274858 | 0.83 | CASP6 (0.74) | PRMT1CASP6NSD2DUSP3PTPN5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3102637-B1 | METHOD FOR PURIFICATION OF ANTIBODIES, ANTIBODY FRAGMENTS OR ENGINEERED VARIANTS THEREOF USING SPECIFIC ANTHRAQUINONE DYE-LIGAND STRUCTURES | BASF SE (DE) | 2018-04-11 | — | — | EP | disclosed |
| US-20160347789-A1 | Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures | BASF SE (DE) | 2016-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160347789-A1 | Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures | ANTXR2, FCGR3B, IGLV6-57 | PRMT1 3457/4885CASP6 4380/4885NSD2 3814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.